PCP Use of Clover Assistant Correlated with Increased Medication Fills for Patients who Were Previously Non-Adherent
FRANKLIN, Tenn., Jan. 08, 2024 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement company committed to bringing access to great healthcare to everyone on Medicare, today released research demonstrating Clover Assistant’s impact on medication adherence.
- FRANKLIN, Tenn., Jan. 08, 2024 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement company committed to bringing access to great healthcare to everyone on Medicare, today released research demonstrating Clover Assistant’s impact on medication adherence.
- The paper, Clover Assistant Use and Medication Adherence for Common Chronic Conditions , examines the correlation between Primary Care Physician (PCP) use of Clover Assistant and levels of adherence to prescribed medications for common chronic conditions including diabetes, high blood pressure, and high cholesterol.
- The lead author of the study, Dr. Kumar Dharmarajan, Chief Medical Officer of Clover Assistant, Adjunct Professor at Yale, and practicing cardiologist said, “Clinicians have no idea if patients pick up their prescribed medications at the pharmacy.
- To learn more about Clover Assistant visit: www.cloverassistant.com